Objective: To analyze long-term continence, voiding dysfunction and secondary prolapse rates following Turner-Warwick Vaginal Obturator Shelf Urethral Repositioning colposuspension (VOSURP) for urodynamically proven stress urinary incontinence (USUI). Patients and Methods: Telephone and/or outpatient review of the outcomes of 50 consecutive patients undergoing VOSURP between 1997 and 2008 was conducted. Outcomes assessed included urinary continence (pad free/leak free), need to self-catheterise (ISC), secondary posterior pelvic organ prolapse (POP) development and need for further continence and POP-related surgical interventions. All patients with continued/recurrent urinary incontinence had repeat videourodynamics. Results: At a median follow-up of 108.5 months (17-153), complete urinary continence was reported in 41 (82%) of patients, post procedure new onset ISC in 2 (4%) and new onset posterior POP in 2 (4%). The cause of continued urinary incontinence was persistent USUI in 3 (6%), new onset idiopathic detrusor overactivity (IDO) in 4 (8%) and failure of resolution of pre-existing IDO in 2 (4%). Conclusions: Long-term complete urinary continence and cure of USUI following VOSURP are excellent at 82 and 94%, respectively. Voiding dysfunction and secondary POP procedure rates are low. The VOSURP is an excellent alternative to classical Burch colposuspension for the treatment of primary and recurrent USUI.

Keywords:
VOSURP, Colposuspension, Stress, Urinary, Incontinence, Posterior, Pelvic, Organ, Prolapse
1.
Lapitan MC, Cody JD, Grant A: Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2009;15:CD002912.
2.
Ward K, Hilton P: Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 2002;325:67.
3.
Goepel M, Bross S: [Stress incontinence in women. Is there still an indication to perform the Burch colposuspension and the fascial sling procedure?]. Urologe A 2009;48:487-490.
4.
Turner-Warwick RT: Vaginal obturator shelf colposuspension; in Practical Aspects of Urinary Incontinence, 1986, pp 100-104.
5.
Shah HN, Badlani GH: Mesh complications in female pelvic floor reconstructive surgery and their management: a systematic review. Indian J Urol 2012;28:129-153.
6.
Medicines and Healthcare Products Regulatory Agency: Summaries of the Safety/Adverse Effects of Vaginal Tapes/Slings/Mesh for Stress Urinary Incontinence and Prolapse.
7.
Shull BL, Baden WF: A six-year experience with paravaginal defect repair for stress urinary incontinence. Am J Obstet Gynecol 1989;160:1432-1439.
8.
Colombo M, Milani R, Vitobello D, Maggioni A: A randomized comparison of Burch colposuspension and abdominal paravaginal defect repair for female stress urinary incontinence. Am J Obstet Gynecol 1996;175:78-84.
9.
Biers SM, Venn SN, Greenwell TJ: The past, present and future of augmentation cystoplasty. BJU Int 2012;109:1280-1293.
10.
McCracken GR, Henderson NA, Ashe RG: Five year follow-up comparing tension-free vaginal tape and colposuspension. Ulster Med J 2007;76:146-149.
11.
Jarvis GJ: Surgery for urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:315-334.
12.
German KA, Kynaston H, Weight S, Stephenson TP: A prospective randomized trial comparing a modified needle suspension procedure with the vagina/obturator shelf procedure for genuine stress incontinence. Br J Urol 1994;74:188-190.
13.
Wiskind AK, Creighton SM, Stanton SL: The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol 1992;167:399-404.
14.
Albo ME, Richter HE, Brubaker L, et al: Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 2007;356:2143-2155.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.